Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Novo Nordisk A/S NVO

Set alert

Price alert · NVO

All alert types
40.45 USD +0.45 +1.13%

At close

40.08 -0.37 -0.93%

Pre-market · Nov 3, 7:23 AM ET

Bid
40.45 × 1,100
Ask
40.46 × 2,100
40.06 Day range 40.78
35.12 52-week range 64.16
YTD
-20.50%
1 year
-17.63%
Open
40.10
Prev close
40.00
Mkt cap
178.41B
Vol
11.18M
Avg vol
12.68M
EPS
4.09
P/E
9.89
Div yield
2.08%
More statistics
Low
40.06
High
40.78
Forward P/E
11.76
Beta
0.37
Short ratio
2.52
Inst. own
9.83%
Dividend
1.80
Ex-div date
Aug 16, 2026
Earnings
Nov 4, 2026
50-d avg
41.23
200-d avg
44.19
1y target
45.09

MAX chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Nov 4, 2026Earnings: —; estimate 0.731; surprise —%
Signals (38)
NameDateAgo
SMA: BearishJul 1, 20251 year ago
MACD: Sell SignalApr 1, 20251 year ago
SMA: BearishOct 1, 20242 years ago
RSI: OverboughtApr 1, 20215 years ago
RSI: OverboughtJul 1, 20206 years ago
MACD: Buy SignalJan 1, 20206 years ago
SMA: BullishJul 1, 20179 years ago
SMA: BullishApr 1, 20179 years ago
SMA: BearishJan 1, 20179 years ago
SMA: BearishJul 1, 201610 years ago
MACD: Sell SignalJul 1, 201610 years ago
RSI: OverboughtOct 1, 201115 years ago
RSI: OverboughtJan 1, 201016 years ago
SMA: BullishJul 1, 200917 years ago
MACD: Buy SignalJul 1, 200917 years ago
MACD: Sell SignalApr 1, 200917 years ago
SMA: BearishJul 1, 200818 years ago
RSI: OverboughtJan 1, 200620 years ago
RSI: OverboughtJul 1, 200422 years ago
MACD: Buy SignalJan 1, 200422 years ago

Newest 20 of 38.

Analyst view

Consensus: hold

Hold
Price target (mean) 45.09 +11.5% upside
Target (low)
39.75
Target (mean)
45.09
Target (high)
61.79
Ratings (0m) 14 3 buy · 10 hold · 1 sell
  • Strong buy0
  • Buy3
  • Hold10
  • Sell1
  • Strong sell0

Recommendation trend

  • This month 14
  • 1 month ago 14
  • 2 months ago 14

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

NVO analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter4.624.01 – 5.284.50+2.7%73.79B-1.6%3
Next quarter4.314.26 – 4.366.04-28.7%76.23B-3.7%2
Current year22.3921.01 – 24.2523.03-2.8%303.54B-1.8%8
Next year22.8921.73 – 23.7422.39+2.3%307.63B+1.4%7

Upgrades and downgrades

The latest rating changes

NVO analyst upgrades and downgrades
DateFirmActionFromTo
Oct 12, 2026BMO CapitalMaintainedMarket PerformMarket Perform
Sep 11, 2026Morgan StanleyDowngradeEqual-WeightUnderweight
Mar 2, 2026Goldman SachsDowngradeBuyNeutral
Feb 24, 2026JP MorganDowngradeOverweightNeutral
Jan 9, 2026CICCInitiated—Outperform
Dec 8, 2025Argus ResearchDowngradeBuyHold
Nov 28, 2025Goldman SachsMaintainedBuyBuy
Nov 25, 2025BMO CapitalMaintainedMarket PerformMarket Perform
Nov 24, 2025HSBCDowngradeBuyHold
Oct 14, 2025BMO CapitalMaintainedMarket PerformMarket Perform
Oct 2, 2025HSBCUpgradeHoldBuy
Sep 29, 2025Morgan StanleyDowngradeEqual-WeightUnderweight
Sep 17, 2025BerenbergUpgradeHoldBuy
Aug 19, 2025TD CowenMaintainedBuyBuy
Aug 5, 2025UBSDowngradeBuyNeutral
Jul 31, 2025HSBCDowngradeBuyHold
Jul 30, 2025BarclaysDowngradeOverweightEqual-Weight
Jun 18, 2025TD CowenReiteratedBuyBuy
Apr 17, 2025BMO CapitalDowngradeOutperformMarket Perform
Jan 8, 2025UBSUpgradeSellBuy
Dec 23, 2024BMO CapitalMaintainedOutperformOutperform
Nov 6, 2024Cantor FitzgeraldReiteratedOverweightOverweight
Oct 22, 2024CitigroupMaintainedBuyBuy
Oct 17, 2024BMO CapitalMaintainedOutperformOutperform
Oct 16, 2024BarclaysMaintainedOverweightOverweight
Oct 14, 2024BMO CapitalMaintainedMarket PerformMarket Perform
Oct 10, 2024Cantor FitzgeraldReiteratedOverweightOverweight
Oct 10, 2024JefferiesInitiated—Buy
Sep 20, 2024Cantor FitzgeraldReiteratedOverweightOverweight
Sep 16, 2024Cantor FitzgeraldReiteratedOverweightOverweight